Rebouche CJ. Carnitine. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern nutrition in health and disease. 10th ed. Philadelphia, Lippincott: Williams & Wilkins; 2006. p. 537–44.

Google Scholar 

Onofrj M, Ciccocioppo F, Varanese S, et al. Acetyl-L-carnitine: from a biological curiosity to a drug for the peripheral nervous system and beyond. Expert Rev Neurother. 2013;13(8):925–36.

Article  CAS  PubMed  Google Scholar 

Farrell S, Vogel J, Bieber LL. Entry of acetyl-L-carnitine into biosynthetic pathways. Biochim Biophys Acta. 1986;876(1):175–7.

Article  CAS  PubMed  Google Scholar 

Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 2004;1033:30–41.

Article  CAS  PubMed  Google Scholar 

Chiechio S, Canonico PL, Grilli M. L-acetylcarnitine: a mechanistically distinctive and potentially rapid-acting antidepressant drug. Int J Mol Sci. 2017. https://doi.org/10.3390/ijms19010011.

Article  PubMed  PubMed Central  Google Scholar 

Sarzi-Puttini P, Giorgi V, Di Lascio S, Fornasari D. Acetyl-L-carnitine in chronic pain: a narrative review. Pharmacol Res. 2021;173:105874.

Article  CAS  PubMed  Google Scholar 

Office of Dietary Supplements NIoH. Dietary Supplement Label Database (DSLD) 2008. Available from: https://ods.od.nih.gov/Research/Dietary_Supplement_Label_Database.aspx. Accessed on 24/09/2025

Agenzia Italiana del Farmaco. L-acetilcarnitina, riassunto delle caratteristiche del prodotto. In: AIFA, editor. 2022.

Therapeutic Goods Administration AG. Acetyl-L-carnitine 2025. Available from: https://www.ebs.tga.gov.au/servlet/xmlmillr6?dbid=ebs/PublicHTML/pdfStore.nsf&docid=478366&agid=%28PrintDetailsPublic%29&actionid=1. Accessed on 29/09/2025.

Watson JC, Dyck PJ. Peripheral neuropathy: a practical approach to diagnosis and symptom management. Mayo Clin Proc. 2015;90(7):940–51.

Article  PubMed  Google Scholar 

IASP. Neuropathic pain 2021. Available from: https://www.iasp-pain.org/advocacy/global-year/neuropathic-pain/. Accessed on 25/08/2025.

Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–5.

Article  CAS  PubMed  Google Scholar 

Finnerup NB, Kuner R, Jensen TS. Neuropathic pain: from mechanisms to treatment. Physiol Rev. 2021;101(1):259–301.

Article  CAS  PubMed  Google Scholar 

Manfridi A, Forloni GL, Arrigoni-Martelli E, Mancia M. Culture of dorsal root ganglion neurons from aged rats: effects of acetyl-L-carnitine and NGF. Int J Dev Neurosci. 1992;10(4):321–9.

Article  CAS  PubMed  Google Scholar 

Formenti A, Arrigoni E, Sansone V, et al. Effects of acetyl-L-carnitine on the survival of adult rat sensory neurons in primary cultures. Int J Dev Neurosci. 1992;10(3):207–14.

Article  CAS  PubMed  Google Scholar 

Tomassoni D, Di Cesare Mannelli L, Bramanti V, et al. Treatment with acetyl-L-carnitine exerts a neuroprotective effect in the sciatic nerve following loose ligation: a functional and microanatomical study. Neural Regen Res. 2018;13(4):692–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pourshahidi S, Shamshiri AR, Derakhshan S, et al. The effect of acetyl-L-carnitine (ALCAR) on peripheral nerve regeneration in animal models: a systematic review. Neurochem Res. 2023;48(8):2335–44.

Article  CAS  PubMed  Google Scholar 

Calabrese V, Ravagna A, Colombrita C, et al. Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. J Neurosci Res. 2005;79(4):509–21.

Article  CAS  PubMed  Google Scholar 

Grossini E, De Marchi F, Venkatesan S, et al. Effects of acetyl-L-carnitine on oxidative stress in amyotrophic lateral sclerosis patients: evaluation on plasma markers and members of the neurovascular unit. Antioxidants (Basel). 2023. https://doi.org/10.3390/antiox12101887.

Article  PubMed  PubMed Central  Google Scholar 

Hota KB, Hota SK, Chaurasia OP, Singh SB. Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis. Hippocampus. 2012;22(4):723–36.

Article  CAS  PubMed  Google Scholar 

Gharighnia S, Omidi A, Ragerdi Kashani I, et al. Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model. Int J Neurosci. 2024;134(4):409–19.

Article  CAS  PubMed  Google Scholar 

Keshavarz-Bahaghighat H, Sepand MR, Ghahremani MH, et al. Acetyl-L-carnitine attenuates arsenic-induced oxidative stress and hippocampal mitochondrial dysfunction. Biol Trace Elem Res. 2018;184(2):422–35.

Article  CAS  PubMed  Google Scholar 

Poon HF, Calabrese V, Calvani M, Butterfield DA. Proteomics analyses of specific protein oxidation and protein expression in aged rat brain and its modulation by L-acetylcarnitine: insights into the mechanisms of action of this proposed therapeutic agent for CNS disorders associated with oxidative stress. Antioxid Redox Signal. 2006;8(3–4):381–94.

Article  CAS  PubMed  Google Scholar 

Cruz F, Scott SR, Barroso I, et al. Ontogeny and cellular localization of the pyruvate recycling system in rat brain. J Neurochem. 1998;70(6):2613–9.

Article  CAS  PubMed  Google Scholar 

Scafidi S, Fiskum G, Lindauer SL, et al. Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain. J Neurochem. 2010;114(3):820–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taglialatela G, Navarra D, Cruciani R, et al. Acetyl-L-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats. Exp Gerontol. 1994;29(1):55–66.

Article  CAS  PubMed  Google Scholar 

Wise BL, Seidel MF, Lane NE. The evolution of nerve growth factor inhibition in clinical medicine. Nat Rev Rheumatol. 2021;17(1):34–46.

Article  PubMed  Google Scholar 

Barker PA, Mantyh P, Arendt-Nielsen L, et al. Nerve growth factor signaling and its contribution to pain. J Pain Res. 2020;13:1223–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boucher TJ, Okuse K, Bennett DL, et al. Potent analgesic effects of GDNF in neuropathic pain states. Science. 2000;290(5489):124–7.

Article  CAS  PubMed  Google Scholar 

Chiechio S, Caricasole A, Barletta E, et al. L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol Pharmacol. 2002;61(5):989–96.

Article  CAS  PubMed  Google Scholar 

Chiechio S, Copani A, De Petris L, et al. Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine. Mol Pain. 2006;2:20.

Article  PubMed  PubMed Central  Google Scholar 

Cuccurazzu B, Bortolotto V, Valente MM, et al. Upregulation of mGlu2 receptors via NF-kappaB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine. Neuropsychopharmacology. 2013;38(11):2220–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gerra MC, Carnevali D, Pedersen IS, et al. DNA methylation changes in genes involved in inflammation and depression in fibromyalgia: a pilot study. Scand J Pain. 2021;21(2):372–83.

Article  PubMed  Google Scholar 

Notartomaso S, Mascio G, Bernabucci M, et al. Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain. Mol Pain. 2017;13:1744806917697009.

Article  CAS